This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

KYTHERA Biopharmaceuticals Inc (KYTH)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 111.52M 79.31M 34.58M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 173.28M 87.59M 44.33M
Property, Plant & Equipment, Gross 1.36M 1.32M 1.13M
Accumulated Depreciation & Depletion 1.27M 1.04M 408.00K
Property, Plant & Equipment, Net 94.00K 275.00K 720.00K
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 37.00K 8.36M 31.00K
Total Non-Current Assets 131.00K 8.63M 751.00K
Liabilities & Shareholder Equity
Total Assets 173.41M 96.22M 45.08M
Accounts Payable 3.23M 2.15M 962.00K
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 4.95M
Total Current Liabilities 17.58M 16.22M 14.80M
Long Term Debt 5.98M 2.76M 0.00
Deferred Income Taxes 8.00K 9.00K 7.00K
Other Non-Current Liabilities 0.00 8.32M 3.70M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 5.99M 11.09M 111.30M
Total Liabilities 23.57M 27.32M 126.10M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 149.84M 68.91M -81.02M
Common Par 0.00 0.00 0.00
Additional Paid In Capital 322.05M 189.21M 2.48M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -172.22M -120.31M -83.51M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 4.00K 0.00 0.00
Total Capitalization 155.82M 71.67M -81.02M
Total Equity 149.84M 68.91M -81.02M
Total Liabilities & Stock Equity 173.41M 96.22M 45.08M
Total Common Shares Outstanding 21.74M 18.32M 17.37M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 19.15M 14.06M 11.15M
Diluted Weighted Shares Outstanding 19.15M 14.06M 11.15M
Number of Employees 64 46 NA
Number of Part-Time Employees 0 0 NA
KYTH News

KYTH KYTHERA Biopharmaceuticals Inc

Analysts Ratings for KYTH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET KYTH ANALYST REPORT

Brokerage Partners

KYTH Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs